Homepage / The European Pharmacopoeia / European Pharmacopoeia / How we work
How we work

The European Pharmacopoeia Commission allocates the work on monographs to specially constituted groups of experts and working parties. The member of these groups come from regulatory authorities, official medicines control laboratories, pharmaceutical and chemical manufacturers, universities and research institutions. All monographs are verified experimentally and submitted to public consultation before inclusion in the European Pharmacopoeia.
The texts are regularly updated, taking into account the changes in marketed products and scientific progress.
The European Pharmacopoeia Commission has decided to schedule its work on active substances so that monographs are produced a few years before the patent expiry date, thus making it possible to assess dossiers on generics on the basis of existing monographs and related certificates of suitability.
The principles of elaboration of monographs are continually adapted to keep pace with regulatory needs in the public health area (licensing, control and inspection authorities), with industrial constraints, and with technological or scientific advances.
Three types of revision can be envisaged:
7 allée Kastner, CS 30026, F67081 Strasbourg, France - Tel. +33 (0)3 88 41 30 30 - Fax +33 (0)3 88 41 27 71
Created by 2exVia with MasterEdit®